Victrelis and Hypoaesthesia oral - a phase IV clinical study of FDA data

Summary:

Hypoaesthesia oral is reported as a side effect among people who take Victrelis (boceprevir), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Ribavirin,.

The phase IV clinical study analyzes which people have Hypoaesthesia oral when taking Victrelis. It is created by eHealthMe based on reports of 8,612 people who have side effects when taking Victrelis from the FDA, and is updated regularly.

What is Victrelis?

Victrelis has active ingredients of boceprevir. It is often used in hepatitis c. eHealthMe is studying from 8,634 Victrelis users. Check the latest studies of Victrelis.

What is Hypoaesthesia oral?

Hypoaesthesia oral (reduced sense of touch or sensation in mouth) is found to be associated with 1,085 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Hypoaesthesia oral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

8,612 people reported to have side effects when taking Victrelis.
Among them, 11 people (0.13%) have Hypoaesthesia oral.

Could Victrelis cause Hypoaesthesia oral?

Among these 11 people:

How long have people been on Victrelis when they have Hypoaesthesia oral? *

What is the gender of people who have Hypoaesthesia oral when taking Victrelis? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Hypoaesthesia oral when taking Victrelis? *

What are other drugs people take besides Victrelis? *

What are other side effects people have besides Hypoaesthesia oral? *

Glossodynia (a burning or painful sensation in the tongue): 8 people, 72.73%
Taste - Impaired: 7 people, 63.64%
Nausea (feeling of having an urge to vomit): 7 people, 63.64%
White Blood Cell Count Decreased: 5 people, 45.45%
Diarrhea: 5 people, 45.45%
Oral Pain: 4 people, 36.36%
Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances)): 4 people, 36.36%
Blood Bilirubin Increased: 4 people, 36.36%
Tinnitus (a ringing in the ears): 4 people, 36.36%
Thrombocytopenia (decrease of platelets in blood): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Victrelis and have Hypoaesthesia oral?

- Check whether Hypoaesthesia oral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Victrelis:

Victrelis (8,634 reports)

Browse all side effects of Victrelis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoaesthesia oral:

Hypoaesthesia oral (1,085 drugs)

Browse all the conditions that are associated with Hypoaesthesia oral:

Hypoaesthesia oral (1,015 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on boceprevir (the active ingredients of Victrelis) and Victrelis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.